clinical trial · NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Prostate CancerProstatic Neoplasms64Cu-SAR-bisPSMA
brief summary
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
started
Dec 21, 2023
primary completion
Sep 1, 2026
completion
Sep 1, 2026
last updated
Apr 9, 2026
official title
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol